| Mrs Amy S Baker, SLP | |
|
245 N 3rd E, Mountain Home, ID 83647-2734 | |
| (208) 587-8255 | |
| (208) 587-4475 |
| Full Name | Mrs Amy S Baker |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 245 N 3rd E, Mountain Home, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508012675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 104084 (Texas) | Secondary |
| 235Z00000X | Speech-language Pathologist | SLP-1973 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amy S Baker, SLP 245 N 3rd E, Mountain Home, ID 83647-2734 Ph: (208) 587-8255 | Mrs Amy S Baker, SLP 245 N 3rd E, Mountain Home, ID 83647-2734 Ph: (208) 587-8255 |
News Archive
Mirati Therapeutics, Inc. today announced that the first patient with Non-Small Cell Lung Cancer (NSCLC) has been dosed in a Phase 1b clinical trial of MGCD265 in selected patients exhibiting genetic alterations of MET or Axl.
Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced positive clinical data from the company's recently expanded U.S. early feasibility study evaluating the safety of the investigational AccuCinch Ventricular Repair System designed for the treatment of heart failure and functional mitral regurgitation.
U.S. Renal Care, Inc., a privately-held leading provider of outpatient dialysis services, today announced that it has entered into definitive agreements with respect to the financing of its cash tender offer to acquire all of the outstanding shares of common stock of Dialysis Corporation of America as contemplated by the debt commitment letter with RBC Capital Markets, dated as of April 13, 2010.
Videos and creative uses of other visuals provide a novel way to obtain informed consent during clinical trials to improve participants' understanding and retention of trial information, according to a study by Nemours Children's Health System presented at the American Thoracic Society (ATS) Annual Conference.
Mayo Clinic researchers, as part of a nine-site study, helped discover the best of three currently-used treatments for convergence insufficiency in children. Convergence refers to the natural ability of the eyes to focus and align while viewing objects up close.
› Verified 8 days ago
Miss Terri Lynn Grasham, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 245 N 3rd E, Mountain Home, ID 83647 Phone: 208-587-8255 Fax: 208-587-4475 | |
Karissa Rutten, MS CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 245 N 3rd E, Mountain Home, ID 83647 Phone: 208-587-8255 Fax: 208-587-4475 | |
Teresa Michelle Johnson, MS CF-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 245 N 3rd E, Mountain Home, ID 83647 Phone: 208-587-8255 | |
Rachelle Ruffing, MSCCC SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 245 N 3rd E, Mountain Home, ID 83647 Phone: 208-599-2536 Fax: 208-587-5734 | |
Ms. Anna Gale Estes-waddell, M.A., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1653 Se Hamilton Rd, Mountain Home, ID 83647 Phone: 208-587-4658 | |
Makenzi Walsh, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 245 N 3rd E, Mountain Home, ID 83647 Phone: 208-898-0988 | |
Jessica Cristobal, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 245 N 3rd E, Mountain Home, ID 83647 Phone: 208-587-8255 |